• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Overexpression of Promotes Peritoneal Dissemination Epithelial-to-Mesenchymal Transition in Gastric Cancer.[蛋白名称]的过表达促进胃癌腹膜播散及上皮-间质转化
Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):313-320. doi: 10.21873/cgp.20089.
2
Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.鉴定 ARL4C 为胃癌腹膜转移相关基因及其临床意义。
Ann Surg Oncol. 2018 Mar;25(3):745-753. doi: 10.1245/s10434-017-6292-6. Epub 2017 Dec 21.
3
Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.LOXL1 可能通过促进 EMT 与胃癌腹膜转移相关。
PLoS One. 2020 Oct 23;15(10):e0241140. doi: 10.1371/journal.pone.0241140. eCollection 2020.
4
FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).成纤维细胞生长因子1-成纤维细胞生长因子受体1轴通过上皮-间质转化促进舌鳞状细胞癌转移。
Biochem Biophys Res Commun. 2015 Oct 23;466(3):327-32. doi: 10.1016/j.bbrc.2015.09.021. Epub 2015 Sep 8.
5
A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.一种由转化生长因子-β激活的长链非编码RNA是胃癌的独立预后标志物。
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S915-22. doi: 10.1245/s10434-015-4554-8. Epub 2015 May 19.
6
PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.PLA2G2A 在胃癌腹膜转移中的潜在调控作用。
Int J Cancer. 2018 Sep 1;143(5):1202-1211. doi: 10.1002/ijc.31410. Epub 2018 Apr 20.
7
Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.联合上皮-间质转化与癌症干细胞样标志物作为胃癌根治性切除术后复发的预测指标。
World J Surg Oncol. 2014 Dec 2;12:368. doi: 10.1186/1477-7819-12-368.
8
Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.肌钙蛋白 I2 作为胃癌腹膜转移预测的特异性生物标志物。
Ann Surg Oncol. 2018 Jul;25(7):2083-2090. doi: 10.1245/s10434-018-6480-z. Epub 2018 Apr 16.
9
Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.弥漫型和肠型胃癌中FGFR1-4表达的不同临床意义。
World J Surg Oncol. 2017 Jan 5;15(1):2. doi: 10.1186/s12957-016-1081-4.
10
ASO Author Reflections: ARL4C and Peritoneal Dissemination in Gastric Cancer.ASO作者反思:ARL4C与胃癌腹膜播散
Ann Surg Oncol. 2019 Dec;26(Suppl 3):547. doi: 10.1245/s10434-018-7056-7. Epub 2018 Dec 17.

引用本文的文献

1
A Case of Lung Squamous Cell Carcinoma Harboring TP53 Mutation and PLPP5-FGFR1 Fusion Gene.一例携带TP53突变和PLPP5-FGFR1融合基因的肺鳞状细胞癌病例
Clin Respir J. 2025 Apr;19(4):e70074. doi: 10.1111/crj.70074.
2
Spatial distribution and functional relevance of FGFR1 and FGFR2 expression for glioblastoma tumor invasion.成胶质细胞瘤肿瘤侵袭中 FGFR1 和 FGFR2 表达的空间分布和功能相关性。
Cancer Lett. 2023 Sep 1;571:216349. doi: 10.1016/j.canlet.2023.216349. Epub 2023 Aug 12.
3
Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer.Rab27b,一种外泌体分泌的调节剂,与胃癌腹膜转移相关。
Cancer Genomics Proteomics. 2023 Jan-Feb;20(1):30-39. doi: 10.21873/cgp.20362.
4
A novel small molecule RK-019 inhibits -amplification gastric cancer cell proliferation and induces apoptosis and .一种新型小分子RK-019抑制胃癌细胞增殖并诱导凋亡。
Front Pharmacol. 2022 Sep 21;13:998199. doi: 10.3389/fphar.2022.998199. eCollection 2022.
5
miRNA-34b/c regulates mucus secretion in RSV-infected airway epithelial cells by targeting FGFR1.miRNA-34b/c 通过靶向 FGFR1 调节 RSV 感染的气道上皮细胞中的黏液分泌。
J Cell Mol Med. 2021 Nov;25(22):10565-10574. doi: 10.1111/jcmm.16988. Epub 2021 Oct 12.
6
Cancer-associated Fibroblast-derived Spondin-2 Promotes Motility of Gastric Cancer Cells.癌相关成纤维细胞衍生的 Spondin-2 促进胃癌细胞的迁移。
Cancer Genomics Proteomics. 2021 Jul-Aug;18(4):521-529. doi: 10.21873/cgp.20277.
7
Update on molecular biomarkers for diagnosis and prediction of prognosis and treatment responses in gastric cancer.胃癌诊断、预后预测及治疗反应的分子生物标志物研究进展
Histol Histopathol. 2021 Aug;36(8):817-832. doi: 10.14670/HH-18-326. Epub 2021 Mar 9.
8
Design and Synthesis of Novel Nordihydroguaiaretic Acid (NDGA) Analogues as Potential FGFR1 Kinase Inhibitors With Anti-Gastric Activity and Chemosensitizing Effect.新型去甲二氢愈创木酸(NDGA)类似物的设计与合成:作为具有抗胃癌活性和化学增敏作用的潜在FGFR1激酶抑制剂
Front Pharmacol. 2020 Sep 11;11:518068. doi: 10.3389/fphar.2020.518068. eCollection 2020.
9
Hsa_circRNA_0000518 facilitates breast cancer development via regulation of the miR-326/FGFR1 axis.hsa_circRNA_0000518 通过调控 miR-326/FGFR1 轴促进乳腺癌的发展。
Thorac Cancer. 2020 Nov;11(11):3181-3192. doi: 10.1111/1759-7714.13641. Epub 2020 Oct 1.
10
Proteomic Technology "Lens" for Epithelial-Mesenchymal Transition Process Identification in Oncology.蛋白质组学技术在肿瘤学上皮-间质转化过程鉴定中的“透镜”作用。
Anal Cell Pathol (Amst). 2019 Oct 29;2019:3565970. doi: 10.1155/2019/3565970. eCollection 2019.

本文引用的文献

1
Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer.抗寄生虫药物伊维菌素通过抑制胃癌中Yes相关蛋白1的表达发挥抗肿瘤作用。
Oncotarget. 2017 Nov 21;8(64):107666-107677. doi: 10.18632/oncotarget.22587. eCollection 2017 Dec 8.
2
Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.鉴定 ARL4C 为胃癌腹膜转移相关基因及其临床意义。
Ann Surg Oncol. 2018 Mar;25(3):745-753. doi: 10.1245/s10434-017-6292-6. Epub 2017 Dec 21.
3
SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models.SOMCL-085,一种新型的多靶点 FGFR 抑制剂,在 FGFR 依赖性人类癌症模型中显示出强大的抗癌活性。
Acta Pharmacol Sin. 2018 Feb;39(2):243-250. doi: 10.1038/aps.2017.96. Epub 2017 Sep 14.
4
Review of recent molecular landscape knowledge of gastric cancer.近期胃癌分子格局知识综述。
Histol Histopathol. 2018 Jan;33(1):11-26. doi: 10.14670/HH-11-898. Epub 2017 Apr 27.
5
A novel non-ATP competitive FGFR1 inhibitor with therapeutic potential on gastric cancer through inhibition of cell proliferation, survival and migration.一种新型非ATP竞争性FGFR1抑制剂,通过抑制细胞增殖、存活和迁移,对胃癌具有治疗潜力。
Apoptosis. 2017 Jun;22(6):852-864. doi: 10.1007/s10495-017-1361-7.
6
Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.弥漫型和肠型胃癌中FGFR1-4表达的不同临床意义。
World J Surg Oncol. 2017 Jan 5;15(1):2. doi: 10.1186/s12957-016-1081-4.
7
Synthesis, biological evaluation, QSAR and molecular dynamics simulation studies of potential fibroblast growth factor receptor 1 inhibitors for the treatment of gastric cancer.用于治疗胃癌的潜在成纤维细胞生长因子受体1抑制剂的合成、生物学评价、定量构效关系及分子动力学模拟研究
Eur J Med Chem. 2017 Feb 15;127:885-899. doi: 10.1016/j.ejmech.2016.10.066. Epub 2016 Nov 1.
8
Molecular mechanisms of peritoneal dissemination in gastric cancer.胃癌腹膜播散的分子机制
World J Gastroenterol. 2016 Aug 14;22(30):6829-40. doi: 10.3748/wjg.v22.i30.6829.
9
Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors.FGFR/FGF和PI3K/AKT/mTOR这两种改变的同时存在,使接受PI3K/AKT/mTOR抑制剂治疗的转移性乳腺癌患者的预后得到改善。
Oncoscience. 2016 Jun 30;3(5-6):164-72. doi: 10.18632/oncoscience.307. eCollection 2016.
10
Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination.人胃癌的综合分子谱分析确定DDR2为腹膜播散的潜在调节因子。
Sci Rep. 2016 Mar 3;6:22371. doi: 10.1038/srep22371.

[蛋白名称]的过表达促进胃癌腹膜播散及上皮-间质转化

Overexpression of Promotes Peritoneal Dissemination Epithelial-to-Mesenchymal Transition in Gastric Cancer.

作者信息

Shimizu Dai, Saito Tomoko, Ito Shuhei, Masuda Takaaki, Kurashige Junji, Kuroda Yosuke, Eguchi Hidetoshi, Kodera Yasuhiro, Mimori Koshi

机构信息

Department of Surgery, Kyushu University Beppu Hospital, Tsurumihara, Japan.

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):313-320. doi: 10.21873/cgp.20089.

DOI:10.21873/cgp.20089
PMID:29976636
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6070707/
Abstract

BACKGROUND

Peritoneal dissemination (PD) is one of the most common causes of cancer-related mortality in gastric cancer (GC). We aimed to identify PD-associated genes and investigate their role in GC.

MATERIALS AND METHODS

We identified FGFR1 as a putative PD-associated gene using a bioinformatics approach. The biological significance of FGFR1 in epithelial-to-mesenchymal transition (EMT) was evaluated according to the correlation with genes that participated in EMT and FGFR1 knockdown experiments. The associations between FGFR1 expression and the clinicopathological features were examined.

RESULTS

FGFR1 expression positively correlated with SNAI1, VIM and ZEB1 expression, and negatively correlated with CDH1 expression. Knockdown of FGFR1 suppressed the malignant phenotype of GC cells. High FGFR1 expression significantly correlated with the peritoneal lavage cytology and synchronous PD positivity as well as poor prognosis.

CONCLUSION

High FGFR1 expression was associated with PD via promotion of EMT and led to a poor prognosis of GC patients.

摘要

背景

腹膜播散(PD)是胃癌(GC)患者癌症相关死亡的最常见原因之一。我们旨在鉴定与PD相关的基因,并研究它们在胃癌中的作用。

材料与方法

我们采用生物信息学方法将FGFR1鉴定为一个假定的与PD相关的基因。根据FGFR1与参与上皮-间质转化(EMT)的基因的相关性以及FGFR1基因敲低实验,评估FGFR1在上皮-间质转化中的生物学意义。检测FGFR1表达与临床病理特征之间的关联。

结果

FGFR1表达与SNAI1、VIM和ZEB1表达呈正相关,与CDH1表达呈负相关。敲低FGFR1可抑制GC细胞的恶性表型。FGFR1高表达与腹腔灌洗细胞学检查、同步PD阳性以及预后不良显著相关。

结论

FGFR1高表达通过促进EMT与PD相关,并导致GC患者预后不良。